Lv4
460 积分 2021-09-16 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2天前
已完结
Head and Neck Cancer
12天前
已完结
Current Landscape of Antibody-Drug Conjugate Development in Head and Neck Cancer
12天前
已完结
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
12天前
已完结
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study
12天前
已完结
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
12天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
12天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
12天前
已完结
Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
14天前
已完结
Evolving Neoadjuvant, Adjuvant, and Concurrent Systemic Therapy Strategies in Head and Neck Squamous Carcinoma
15天前
已关闭
皖公网安备34019202002308
